health equity – Page 2

Most Host Countries Don’t Get Timely Access to Medicines They Help Test: An Analysis of FDA-Supported Trials (2015–2018)

By MedXY 11/18/2025

A cross-sectional analysis (FDA approvals 2015–2018) found that most countries hosting pivotal trials lack timely market authorization for tested medicines, especially lower- and middle-income countries—raising ethical, regulatory, and policy concerns about equitable post-trial access.

Cardiology Internal Medicine news Public Health

Home‑Delivered DASH Groceries Lower Blood Pressure and LDL in Black Urban Residents — but Benefits Fade After Support Ends

By MedXY 11/10/2025

The GoFresh randomized trial found that 12 weeks of home‑delivered DASH‑patterned groceries plus dietitian counseling reduced systolic BP by 3.4 mm Hg versus cash stipends and lowered LDL; effects were not sustained three months after the intervention ended.

Pediatrics Public Health Specialties

Technology, Ethics, and Equity: Navigating the Three Core Challenges in Large-Scale Genomic Newborn Screening for Universal Health Benefits

By MedXY 09/11/2025

Genomic newborn screening shows promise for early detection of a wider range of diseases but raises significant technological, ethical, and equity challenges before becoming a universally accessible public health tool.

news OB/GYN & Women's Health Specialties

Removing Out-of-Pocket Costs Increases Access to 3D Mammograms

By MedXY 07/29/2025

Eliminating a $45 fee for advanced breast cancer screening technology improves access and reduces health disparities, according to recent research.